Your browser doesn't support javascript.
loading
Cytogenetic profile of 1791 adult acute myeloid leukemia in India.
Srivastava, Vivi M; Nair, Sukesh Chandran; Sappani, Marimuthu; Manipadam, Marie-Therese; Kulkarni, Uday P; Devasia, Anup J; Fouzia, N A; Korula, Anu; Lakshmi, Kavitha M; Abraham, Aby; Srivastava, Alok.
Afiliação
  • Srivastava VM; Department of Cytogenetics, Christian Medical College, Vellore, Tamil Nadu, 632004, India. vivi@cmcvellore.ac.in.
  • Nair SC; Department of Transfusion Medicine and Immunohaematology, Christian Medical College, Vellore, Tamil Nadu, 632004, India.
  • Sappani M; Department of Biostatistics, Christian Medical College, Vellore, Tamil Nadu, 632002, India.
  • Manipadam MT; Department of General Pathology, Christian Medical College, Vellore, Tamil Nadu, 632004, India.
  • Kulkarni UP; Department of Cellular Pathology, Maidstone Hospital, Hermitage Lane, Maidstone, ME169QQ, UK.
  • Devasia AJ; Department of Clinical Haematology, Christian Medical College, Vellore, 632501, Tamil Nadu, India.
  • Fouzia NA; Department of Clinical Haematology, Christian Medical College, Vellore, 632501, Tamil Nadu, India.
  • Korula A; On leave at Princess Margaret Cancer Centre, Toronto, Canada.
  • Lakshmi KM; Department of Clinical Haematology, Christian Medical College, Vellore, 632501, Tamil Nadu, India.
  • Abraham A; Department of Clinical Haematology, Christian Medical College, Vellore, 632501, Tamil Nadu, India.
  • Srivastava A; NCCCR, Doha, Qatar.
Mol Cytogenet ; 16(1): 24, 2023 Sep 16.
Article em En | MEDLINE | ID: mdl-37716945
ABSTRACT

BACKGROUND:

Cytogenetic analysis continues to have an important role in the management of acute myeloid leukemia (AML) because it is essential for prognostication. It is also necessary to diagnose specific categories of AML and to determine the most effective form of treatment. Reports from South Asia are few because the availability of cytogenetic services is relatively limited.

METHODS:

We performed a retrospective analysis of the cytogenetic findings in adults with AML seen consecutively in a single centre in India. The results were categorised according to the 2022 World Health Organisation (WHO), International Consensus Classification (ICC) and European LeukemiaNet (ELN) classifications.

RESULTS:

There were 1791 patients aged 18-85 years (median age 42, 1086 males). Normal karyotypes were seen in 646 (36%) patients. The 1145 (64%) abnormal karyotypes comprised 585 (32.7%) with recurrent genetic abnormalities (RGA), 403 (22.5%) with myelodysplasia-related cytogenetic abnormalities (MRC), and 157 (8.8%) with other abnormalities. There were 567 (31.7%) patients with solitary abnormalities and 299 (16.7%) with two abnormalities. Among the 279 (15.6%) patients with ≥ 3 abnormalities, 200 (11.2%) had complex karyotypes (CK) as per the WHO/ICC and 184 (10.3%), as per the ELN definition. There were 158 (8.8%) monosomal karyotypes (MK). Patients with normal karyotypes had a higher median age (45 years) than those with abnormal karyotypes (40 years, p < 0.001), and those with ≥ 3 abnormalities (43 years), than those with fewer abnormalities (39 years, p = 0.005). Patients with CK (WHO/ICC) and monosomal karyotypes had a median age of 48 years. Those with RGA had a lower median age (35 years, p < 0.001) than MRC (46 years) or other abnormalities (44 years). The t(15;17) was the most common abnormality (16.7%),followed by trisomy 8 (11.6%), monosomy 7/del 7q (9.3%), t(8;21) (7.2%), monosomy 5/del 5q (6.7%) and monosomy 17/del 17p (5.2%).

CONCLUSION:

Our findings confirm the lower age profile of AML in India and show similarities and differences with respect to the frequencies of individual abnormalities compared to the literature. The frequencies of the t(15;17), trisomy 8 and the high-risk abnormalities monosomy 7 and monosomy 5/del 5q were higher, and that of the inv(16), lower than in most reports.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Cytogenet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Cytogenet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia